Literature DB >> 11532866

XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.

G Matullo1, D Palli, M Peluso, S Guarrera, S Carturan, E Celentano, V Krogh, A Munnia, R Tumino, S Polidoro, A Piazza, P Vineis.   

Abstract

DNA repair genes have an important role in protecting individuals from cancer-causing agents. Polymorphisms in several DNA repair genes have been identified and individuals with non-dramatic reductions in the capacity to repair DNA damage are observed in the population, but the impact of specific genetic variants on repair phenotype and cancer risk has not yet been clarified. In 308 healthy Italian individuals belonging to the prospective European project EPIC, we have investigated the relationship between DNA damage, as measured by (32)P-DNA adduct levels, and three genetic polymorphisms in different repair genes: XRCC1-Arg399Gln (exon 10), XRCC3-Thr241Met (exon 7) and XPD-Lys751Gln (exon 23). DNA adduct levels were measured as relative adduct level (RAL) per 10(9) normal nucleotides by DNA (32)P-post-labelling assay in white blood cells from peripheral blood. Genotyping was performed by PCR-RFLP analysis. The XRCC3-241Met variant was significantly associated with higher DNA adduct levels, whereas XRCC1-399Gln and XPD-751Gln were associated with higher DNA adduct levels only in never-smokers. XRCC3-241Met homozygotes had an average DNA adduct level of 11.44 +/- 1.48 (+/-SE) compared with 7.69 +/- 0.88 in Thr/Met heterozygotes and 6.94 +/- 1.11 in Thr/Thr homozygotes (F = 3.206, P = 0.042). Never-smoking XRCC1-399Gln homozygotes had an average DNA adduct level of 15.60 +/- 5.42 compared with 6.16 +/- 0.97 in Gln/Arg heterozygotes and 6.78 +/- 1.10 in Arg/Arg homozygotes (F = 5.237, P = 0.007). A significant odds ratio (3.81, 95% CI 1.02-14.16) to have DNA adduct levels above median value was observed for XPD-751Gln versus XPD-751Lys never-smoking homozygotes after adjustment for several confounders. These data show that all the analysed polymorphisms could result in deficient DNA repair and suggest a need for further investigation into the possible interactions between these polymorphisms, smoking and other risk factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532866     DOI: 10.1093/carcin/22.9.1437

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  126 in total

Review 1.  From the bench to the bed: individualizing treatment in non-small-cell lung cancer.

Authors:  Mariacarmela Santarpia; Giuseppe Altavilla; Fernanda Salazar; Miquel Tarón; Rafael Rosell
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

2.  Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer.

Authors:  Mary A Bewick; Robert M Lafrenie; Michael S C Conlon
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-28       Impact factor: 4.553

3.  No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study.

Authors:  Fatima Zohra Moghtit; Meriem Samia Aberkane; Valérie Le Morvan; Lotfi Louhibi; Ricardo Bellot; Abdelkader Bousahba; Ahlem Megaiz; Mostefa Fodil; Sounnia Mediene-Benchekor; Faouzia Zemani-Fodil; Abdallah Boudjema; Jacques Robert; Nadhira Saidi-Mehtar
Journal:  Med Oncol       Date:  2014-04-01       Impact factor: 3.064

4.  Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population.

Authors:  Mehmet Burak Aktuglu; Mesut Ayer; Elif S Bireller; Cagla Rencuzogullari; Hasan Acik; Zeynep Karaali; Taner Alioglu; Namik Yigit; Mustafa Velet; Eray Atalay; Oznur Sari Ure; Bedia Cakmakoglu
Journal:  Med Oncol       Date:  2014-08-26       Impact factor: 3.064

5.  An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer.

Authors:  Dorota Butkiewicz; Marek Rusin; Bożena Sikora; Antonina Lach; Mieczysław Chorąży
Journal:  Mol Biol Rep       Date:  2010-12-28       Impact factor: 2.316

6.  The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.

Authors:  Li Jiao; Manal M Hassan; Melissa L Bondy; James L Abbruzzese; Douglas B Evans; Donghui Li
Journal:  Cancer Lett       Date:  2006-02-03       Impact factor: 8.679

7.  DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy.

Authors:  Angeline S Andrew; Margaret R Karagas; Heather H Nelson; Simonetta Guarrera; Silvia Polidoro; Sara Gamberini; Carlotta Sacerdote; Jason H Moore; Karl T Kelsey; Eugene Demidenko; Paolo Vineis; Giuseppe Matullo
Journal:  Hum Hered       Date:  2007-09-26       Impact factor: 0.444

8.  Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma.

Authors:  Katie M Applebaum; Michael D McClean; Heather H Nelson; Carmen J Marsit; Brock C Christensen; Karl T Kelsey
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

9.  Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt.

Authors:  Vincenzo Formica; Michaela Benassi; Giovanna Del Vecchio Blanco; Elena Doldo; Laura Martano; Ilaria Portarena; Antonella Nardecchia; Jessica Lucchetti; Cristina Morelli; Emilia Giudice; Piero Rossi; Alessandro Anselmo; Pierpaolo Sileri; Giuseppe Sica; Augusto Orlandi; Riccardo Santoni; Mario Roselli
Journal:  Med Oncol       Date:  2018-05-02       Impact factor: 3.064

10.  XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer.

Authors:  Li Jiao; Manal M Hassan; Melissa L Bondy; Robert A Wolff; Douglas B Evans; James L Abbruzzese; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-11-06       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.